近日(ri),由国药(yao)(yao)集团(tuan)中(zhong)(zhong)(zhong)国中(zhong)(zhong)(zhong)药(yao)(yao)控股有限公司主(zhu)办、中(zhong)(zhong)(zhong)国中(zhong)(zhong)(zhong)药(yao)(yao)有限公司承办,中(zhong)(zhong)(zhong)国中(zhong)(zhong)(zhong)医科学院中(zhong)(zhong)(zhong)药(yao)(yao)研(yan)(yan)究所、中(zhong)(zhong)(zhong)国电(dian)子技(ji)术(shu)(shu)标准化研(yan)(yan)究院提供技(ji)术(shu)(shu)支持的“2022年产业技(ji)术(shu)(shu)基础公共(gong)服务平(ping)台(tai)项目——中(zhong)(zhong)(zhong)药(yao)(yao)全产业链(lian)质量技(ji)术(shu)(shu)服务平(ping)台(tai)”建设(she)项目推进(jin)会在(zai)北(bei)京召开。
工(gong)业(ye)(ye)和信息化部消(xiao)费(fei)品(pin)工(gong)业(ye)(ye)司(si)(si)司(si)(si)长何亚琼强调,要充分认识加强中药(yao)质量公共服务能力建(jian)设的(de)重要意义,推动解决制约中药(yao)行业(ye)(ye)发(fa)展(zhan)的(de)突出问(wen)题,促进(jin)产业(ye)(ye)健(jian)康发(fa)展(zhan);发(fa)挥企业(ye)(ye)自身(shen)优势,引(yin)入互联(lian)网(wang)、大数(shu)据(ju)领域资源,服务行业(ye)(ye)、赋(fu)能行业(ye)(ye),切实提升(sheng)中药(yao)全产业(ye)(ye)链(lian)质量技(ji)术(shu)公共服务水平,确保“公共”属性;通过项目(mu)平台的(de)搭建(jian),提高中药(yao)全产业(ye)(ye)链(lian)的(de)质控水平,切实提升(sheng)中药(yao)产品(pin)质量,全力保障人民群众健(jian)康需(xu)求。
中(zhong)国(guo)医药(yao)(yao)(yao)集团有限公(gong)司副(fu)总经理(li)董增贺表(biao)示,中(zhong)国(guo)中(zhong)药(yao)(yao)(yao)控(kong)股作为(wei)国(guo)药(yao)(yao)(yao)集团实现(xian)“四梁八柱(zhu)、百强万亿”总体战(zhan)略规(gui)划目标的重(zhong)要组(zu)成部分(fen),要以(yi)本项目实施为(wei)契(qi)机,组(zu)建协(xie)同产(chan)(chan)业链网络,强化内外战(zhan)略联盟,建设数字化产(chan)(chan)学研融合服务平台和协(xie)同创新(xin)网络,着力构筑“立体式”中(zhong)药(yao)(yao)(yao)产(chan)(chan)业科(ke)技创新(xin)和质量服务格局,整(zheng)体联动推动全国(guo)中(zhong)药(yao)(yao)(yao)产(chan)(chan)业体系(xi)高质量发展。
中(zhong)(zhong)国(guo)中(zhong)(zhong)药(yao)(yao)(yao)(yao)控(kong)股(gu)有限(xian)公司董事长陈映龙(long)表示,中(zhong)(zhong)国(guo)中(zhong)(zhong)药(yao)(yao)(yao)(yao)控(kong)股(gu)作为国(guo)药(yao)(yao)(yao)(yao)集团现代中(zhong)(zhong)药(yao)(yao)(yao)(yao)板块的核心(xin)平台,肩负着践行国(guo)家中(zhong)(zhong)医药(yao)(yao)(yao)(yao)发(fa)展战(zhan)略,引(yin)领中(zhong)(zhong)药(yao)(yao)(yao)(yao)产(chan)业高质(zhi)量(liang)发(fa)展的使命和责任。下(xia)一步,中(zhong)(zhong)国(guo)中(zhong)(zhong)药(yao)(yao)(yao)(yao)控(kong)股(gu)将带动联合体成员单位,不断推进中(zhong)(zhong)医药(yao)(yao)(yao)(yao)产(chan)业数(shu)字化与产(chan)业升级,让(rang)中(zhong)(zhong)医药(yao)(yao)(yao)(yao)在新时代焕发(fa)出(chu)新的光(guang)彩。
据了(le)解,“中(zhong)(zhong)药(yao)(yao)(yao)(yao)全产业(ye)链质(zhi)(zhi)量(liang)技(ji)术服务(wu)平(ping)台”建设项目由“中(zhong)(zhong)药(yao)(yao)(yao)(yao)全产业(ye)链质(zhi)(zhi)量(liang)可追(zhui)溯(su)数(shu)据平(ping)台”“中(zhong)(zhong)药(yao)(yao)(yao)(yao)全过程质(zhi)(zhi)量(liang)控制检(jian)(jian)验(yan)检(jian)(jian)测平(ping)台”“中(zhong)(zhong)药(yao)(yao)(yao)(yao)创新成果产业(ye)化(hua)公共服务(wu)平(ping)台”三部分构成,共建三位一(yi)体(ti)的数(shu)字化(hua)中(zhong)(zhong)药(yao)(yao)(yao)(yao)全产业(ye)链数(shu)据信息(xi)系(xi)统。项目建成后将(jiang)为行业(ye)提供(gong)中(zhong)(zhong)药(yao)(yao)(yao)(yao)产业(ye)管(guan)理(li)、中(zhong)(zhong)药(yao)(yao)(yao)(yao)新药(yao)(yao)(yao)(yao)开发(fa)、检(jian)(jian)验(yan)检(jian)(jian)测服务(wu)、快速检(jian)(jian)测服务(wu)、中(zhong)(zhong)药(yao)(yao)(yao)(yao)大品种二次开发(fa)、追(zhui)溯(su)数(shu)字化(hua)服务(wu)、药(yao)(yao)(yao)(yao)理(li)药(yao)(yao)(yao)(yao)效和安全性评(ping)价、质(zhi)(zhi)量(liang)管(guan)理(li)体(ti)系(xi)建设服务(wu)、知识服务(wu)、成果转化(hua)服务(wu)、中(zhong)(zhong)药(yao)(yao)(yao)(yao)产品或企业(ye)评(ping)价等服务(wu)。
经济日报新闻客户端
编辑:吉亚矫 责编:顾阳
近(jin)日,由国药集团中国中药控(kong)股有限(xian)公司主办、中国中药有限(xian)公司承(cheng)办,中国中医科学院中药研(yan)究所、中国电子技(ji)术标准化研(yan)究院提供(gong)技(ji)术支持的(de)“2022年产业技(ji)术基础(chu)公共服务(wu)平(ping)(ping)台项目——中药全产业链质量技(ji)术服务(wu)平(ping)(ping)台”建设项目推(tui)进会(hui)在北京召开。
工(gong)业(ye)(ye)(ye)(ye)和(he)信息(xi)化部消(xiao)费品(pin)工(gong)业(ye)(ye)(ye)(ye)司(si)司(si)长何亚琼强(qiang)调,要(yao)充(chong)分认(ren)识加(jia)强(qiang)中(zhong)(zhong)药(yao)质量(liang)公(gong)(gong)共(gong)(gong)服务(wu)能(neng)力建(jian)设的重要(yao)意义,推动解决制约(yue)中(zhong)(zhong)药(yao)行(xing)业(ye)(ye)(ye)(ye)发(fa)展的突出问题,促进(jin)产业(ye)(ye)(ye)(ye)健康(kang)发(fa)展;发(fa)挥企业(ye)(ye)(ye)(ye)自身优势,引入互联(lian)网(wang)、大数据(ju)领域资源(yuan),服务(wu)行(xing)业(ye)(ye)(ye)(ye)、赋(fu)能(neng)行(xing)业(ye)(ye)(ye)(ye),切(qie)实提(ti)升中(zhong)(zhong)药(yao)全(quan)产业(ye)(ye)(ye)(ye)链质量(liang)技术公(gong)(gong)共(gong)(gong)服务(wu)水平,确保“公(gong)(gong)共(gong)(gong)”属性;通过项目平台(tai)的搭建(jian),提(ti)高中(zhong)(zhong)药(yao)全(quan)产业(ye)(ye)(ye)(ye)链的质控水平,切(qie)实提(ti)升中(zhong)(zhong)药(yao)产品(pin)质量(liang),全(quan)力保障(zhang)人民(min)群众(zhong)健康(kang)需求(qiu)。
中(zhong)国医药(yao)集团(tuan)有(you)限(xian)公司(si)副总经理董增贺表示,中(zhong)国中(zhong)药(yao)控(kong)股作(zuo)为国药(yao)集团(tuan)实现“四梁八柱、百强万亿”总体(ti)战略规划目(mu)标(biao)的重(zhong)要(yao)组成部分,要(yao)以本项目(mu)实施(shi)为契机,组建协同产业(ye)(ye)链网络(luo),强化内外(wai)战略联盟(meng),建设数字化产学研融合服务平(ping)台(tai)和(he)协同创(chuang)(chuang)新网络(luo),着(zhe)力构筑“立体(ti)式(shi)”中(zhong)药(yao)产业(ye)(ye)科技创(chuang)(chuang)新和(he)质(zhi)量服务格局,整体(ti)联动推动全国中(zhong)药(yao)产业(ye)(ye)体(ti)系高质(zhi)量发展。
中(zhong)国中(zhong)药(yao)控(kong)股(gu)有限公司(si)董事长陈映龙表示,中(zhong)国中(zhong)药(yao)控(kong)股(gu)作为(wei)国药(yao)集(ji)团现代中(zhong)药(yao)板块的核心(xin)平台(tai),肩负着践行(xing)国家中(zhong)医药(yao)发展战略,引领中(zhong)药(yao)产(chan)业高质(zhi)量发展的使命和责(ze)任。下(xia)一(yi)步,中(zhong)国中(zhong)药(yao)控(kong)股(gu)将带动联合(he)体成(cheng)员单位,不断推进中(zhong)医药(yao)产(chan)业数字化与产(chan)业升级,让中(zhong)医药(yao)在新(xin)时代焕发出新(xin)的光彩。
据(ju)了解(jie),“中(zhong)(zhong)药(yao)(yao)全(quan)产(chan)(chan)业(ye)链质(zhi)量技术服(fu)务(wu)(wu)(wu)(wu)平(ping)台(tai)”建(jian)设(she)项(xiang)目由“中(zhong)(zhong)药(yao)(yao)全(quan)产(chan)(chan)业(ye)链质(zhi)量可追溯(su)数据(ju)平(ping)台(tai)”“中(zhong)(zhong)药(yao)(yao)全(quan)过(guo)程质(zhi)量控制(zhi)检(jian)验检(jian)测(ce)平(ping)台(tai)”“中(zhong)(zhong)药(yao)(yao)创新成果(guo)产(chan)(chan)业(ye)化公共服(fu)务(wu)(wu)(wu)(wu)平(ping)台(tai)”三部分构成,共建(jian)三位一体(ti)的数字化中(zhong)(zhong)药(yao)(yao)全(quan)产(chan)(chan)业(ye)链数据(ju)信(xin)息系统。项(xiang)目建(jian)成后将(jiang)为行业(ye)提供中(zhong)(zhong)药(yao)(yao)产(chan)(chan)业(ye)管理(li)、中(zhong)(zhong)药(yao)(yao)新药(yao)(yao)开发(fa)、检(jian)验检(jian)测(ce)服(fu)务(wu)(wu)(wu)(wu)、快速检(jian)测(ce)服(fu)务(wu)(wu)(wu)(wu)、中(zhong)(zhong)药(yao)(yao)大品(pin)种二次开发(fa)、追溯(su)数字化服(fu)务(wu)(wu)(wu)(wu)、药(yao)(yao)理(li)药(yao)(yao)效和(he)安(an)全(quan)性评(ping)价(jia)、质(zhi)量管理(li)体(ti)系建(jian)设(she)服(fu)务(wu)(wu)(wu)(wu)、知识服(fu)务(wu)(wu)(wu)(wu)、成果(guo)转(zhuan)化服(fu)务(wu)(wu)(wu)(wu)、中(zhong)(zhong)药(yao)(yao)产(chan)(chan)品(pin)或企(qi)业(ye)评(ping)价(jia)等服(fu)务(wu)(wu)(wu)(wu)。
经济日报新闻客户端
编辑:吉亚矫 责编:顾阳